Mauna Kea Technologies SA (EPA:ALMKT)

Market Cap	11.24M
Revenue (ttm)	8.16M
Net Income (ttm)	-11.21M
Shares Out	64.61M
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,654
Average Volume	74,596
Open	0.172
Previous Close	0.173
Day's Range	0.170 - 0.173
52-Week Range	0.162 - 0.525
Beta	1.42
RSI	47.94
Earnings Date	Apr 24, 2025

About Mauna Kea Technologies

Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 68
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMKT

Financial Performance

In 2023, Mauna Kea Technologies's revenue was 11.03 million, an increase of 35.97% compared to the previous year's 8.11 million. Losses were -3.73 million, -66.66% less than in 2022.